Our clinical trial

We conducted an independent, open-label, 8-week clinical study with 38 women aged 25–50 who reported poor sleep, low energy, and fatigue in the month prior to enrollment.

Participants took two capsules of THRIVE: Women’s Daily + Cortisol Support each morning with food and completed validated questionnaires at baseline, week 4, and week 8.

Mental and emotional well-being outcomes were assessed using clinically validated tools:

• Oxford Happiness Questionnaire (short form) to measure overall happiness
• GAD-7 to assess anxiety symptoms
• Perceived Stress Scale (PSS) to evaluate stress levels

These measures were used to evaluate the product’s impact on happiness, anxiety, and perceived stress over time.